Abstract
Mutations in the gene encoding the enzyme iduronate-2-sulfatase (IDS) were reported as the cause of the X-linked recessive lysosomal disease, mucopolysaccharidosis II (MPS II). Amongst the different mutations, it emerges that nearly 10% are nucleotide substitutions causing splicing mutations. We now report the molecular characterisation of three MPS II patients with multiple aberrant transcripts due to three different point mutations. The c.418+1G>C that occurred in the invariant splice-site motif, produced only aberrantly spliced transcripts. Whilst the mutations affecting variant motifs (c.419G>T) or coding regions (c.245C>T) led to aberrantly spliced transcripts in addition to correctly spliced transcripts with the respective predicted missense mutation, p.G140V or p.A82V. A combination of experimental tests and computational approaches were used to understand the molecular basis underlying the altered transcription patterns. In addition, by using real-time reverse transcriptase polymerase chain reaction, the reduction of mRNA amount in two patients observed was likely due to nonsense-mediated mRNA decay pathway. Overall, our results further emphasised the importance of cloning and sequencing independent transcripts to reveal less abundant, aberrant products, which often could not be detected by direct sequencing. Moreover, the different splicing patterns observed in the three patients as a consequence of point mutations show how sensitive the balance is between constitutive and cryptic splice sites in the IDS gene. The generation of such diverse transcripts, together with their level of expression, could contribute to the profound phenotypic variability reported in MPS II.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WE, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452
Wilson PJ, Morris CP, Anson DS, Occhiodoro T, Bielicki J, Clements PR, Hopwood JJ (1990) Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci 87:8531–8535
Bondeson ML, Malmgren H, Dahl N, Carlberg BM, Pettersson U (1995) Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome. Eur J Hum Genet 3:219–227
Rathmann M, Bunge S, Steglich C, Schwinger E, Gal A (1995) Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3–q28. Hum Genet 95:34–38
Timms KM, Lu F, Shen Y, Pierson CA, Muzny DM, Gu Y, Nelson DL, Gibbs RA (1995) 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. Genome Res 5:71–78
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human gene mutation database (HGMD): 2003 update. Hum Mutat 21:577–581
Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54
Pagani F, Baralle FE (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5:389–396
Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285–298
Nissim-Rafinia M, Kerem B (2002) Splicing regulation as a potential genetic modifier. Trends Genet 18:23–27
Flomen RH, Green EP, Green PM, Bentley DR, Giannelli F (1993) Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene. Hum Mol Genet 2:5–10
Bonuccelli G, Regis S, Filocamo M, Corsolini F, Caroli F, Gatti R (1998) A deletion involving exons 2–4 in the iduronate-2-sulfatase gene of a patient with intermediate Hunter syndrome. Clin Genet 53:474–477
Filocamo M, Bonuccelli G, Corsolini F, Mazzotti R, Cusano R, Gatti R (2001) Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: new mutations in the iduronate-2-sulfatase (IDS) gene. Hum Mutat 18:164–165
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor, New York
Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155–7174
Regis S, Grossi S, Lualdi S, Biancheri R, Filocamo M (2005) Diagnosis of Pelizaeus–Merzbacher disease: detection of proteolipid protein gene copy number by real-time PCR. Neurogenetics 6:73–78
Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297:1007–1013
Bai Y, Lee D, Yu T, Chasin LA (1999) Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res 27:126–134
Thanaraj TA, Clark F (2001) Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions. Nucleic Acids Res 29:2581–2593
Maquat LE (2005) Nonsense-mediated mRNA decay in mammals. J Cell Sci 118:1773–1776
Pappalardo E, Zingale LC, Cicardi M (2004) C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR. J Allergy Clin Immunol 114:638–644
Harries LW, Bingham C, Bellanne-Chantelot C, Hattersley AT, Ellard S (2005) The position of premature termination codons in the hepatocyte nuclear factor-1 beta gene determines susceptibility to nonsense-mediated decay. Hum Genet 25:1–11
Moore MJ (2005) From birth to death: the complex lives of eukaryotic mRNAs. Science 309:1514–1518
Daniele A, Faust CJ, Herman GE, Di Natale P, Ballabio A (1993) Cloning and characterization of the cDNA for the murine iduronate sulfatase gene. Genomics 16:755–757
Sardiello M, Annunziata I, Roma G, Ballabio A (2005) Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. Hum Mol Genet 14:3203–3217
Acknowledgements
The samples were obtained from the “Cell Line and DNA Bank from Patients affected by Genetic Diseases” collection (http://www.gaslini.org/labdppm.htm) supported by Italian Telethon grants (project no. GTF04002). We thank the Laboratory of Oncology of G. Gaslini Institute for the use of the ABI Prism 7700 Sequence Detection System.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lualdi, S., Pittis, M.G., Regis, S. et al. Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts. J Mol Med 84, 692–700 (2006). https://doi.org/10.1007/s00109-006-0057-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-006-0057-1